Send us a textWhy are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine?In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI.Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets. This underrepresentation isn’t just a data gap—it’s a clinical risk.We dive into disparities between healthcare systems, the promise of digital pathology as a low-cost entry point, the dangers of “parachute science,” and how Victor is building a living, ethical, transparent biobank through Omica. AI—built for true precision medicine rooted in community trust.Highlights with Timestamps[00:00–01:40] Personal cancer experiences and diagnostic uncertainty[01:40–06:50] Victor’s medical journey across Mexico and the U.S.[06:50–11:42] The digitization gap: empathy vs. tech[11:42–16:43] The “coffee diversity” metaphor for genomic diversity[16:43–19:34] Funding disparities & the biotech cold-start problem[19:34–25:44] Digital pathology as a gateway to precision medicine[25:44–31:44] Avoiding “parachute science” and building community-first research[31:44–36:05] The Nagoya Protocol and benefit-sharing[36:05–41:47] Omica.Ai’s work, goals, and clinical-embedded approach[41:47–49:36] Creating future-proof, embedded biobanks[49:36–53:35] Blockchain for transparency and patient trust[53:35–54:39] Victor’s call to action: collaborate, include, and stay humanResources from This EpisodeOmica.Ai – Community-driven precision medicine platformNagoya Protocol – Framework for equitable biological useKey InsightsCancer is personal—even for experts<1% representation of Latino genomes threatens clinical accuracyDigital pathology + AI can leapfrog infrastructure gapsEthical biobanking requires trust, transparency, and local benefitAvoiding “parachute science” is essentialGenetic diversity drives discovery—but only if we capture itBlockchain + dynamic consent = future of patient-centered dataSupport the showGet the "Digital Pathology 101" FREE E-book and join us!